Dexmedetomidine for reducing succinylcholine-induced myalgia in patients undergoing electroconvulsive therapy: A randomised controlled trial.

MLA

Sriramka, Bhavna, et al. “Dexmedetomidine for Reducing Succinylcholine-Induced Myalgia in Patients Undergoing Electroconvulsive Therapy: A Randomised Controlled Trial.” Indian Journal of Anaesthesia, vol. 68, no. 6, June 2024, pp. 58–63. EBSCOhost, https://doi.org/10.4103/ija.ija_1159_23.

APA

Sriramka, B., Panigrahy, S., Ramasubbu, M. K., & Mishra, S. N. (2024). Dexmedetomidine for reducing succinylcholine-induced myalgia in patients undergoing electroconvulsive therapy: A randomised controlled trial. Indian Journal of Anaesthesia, 68(6), 58–63. https://doi.org/10.4103/ija.ija_1159_23

Chicago

Sriramka, Bhavna, Sasmita Panigrahy, Mathan Kumar Ramasubbu, and Suvendu N. Mishra. 2024. “Dexmedetomidine for Reducing Succinylcholine-Induced Myalgia in Patients Undergoing Electroconvulsive Therapy: A Randomised Controlled Trial.” Indian Journal of Anaesthesia 68 (6): 58–63. doi:10.4103/ija.ija_1159_23.